Quantcast

Latest Breast cancer treatment Stories

2014-09-18 12:29:16

Contract Funds 3D Breast Cancer, 3D Brain Cancer Micro-Tumor Development GREENVILLE, S.C., Sept. 18, 2014 /PRNewswire/ -- KIYATEC announced today that it has been awarded a $1.975 million Small Business Innovation Research (SBIR) Phase II Contract from the National Cancer Institute (NCI), one of the 27 institutes and centers that comprise the National Institutes of Health (NIH). Over the course of the two year award, KIYATEC will expand its 3D breast cancer model to address two...

2014-09-18 08:29:59

Additional Data Demonstrate Accuray TomoTherapy and CyberKnife® Systems Provide Precise Dose Delivery and Tumor Management SUNNYVALE, Calif., Sept. 18, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 56th Annual American Society for Radiation Oncology (ASTRO) Meeting in San Francisco, September 14 - 17, 2014 continue to reinforce broad-based healthcare professional support of the clinical and quality of life benefits the CyberKnife® and...

2014-09-17 20:22:13

Oral presentation at American Society for Radiation Oncology Annual Meeting describes Decipher's ability to identify high-risk prostate cancer patients that may benefit from radiation therapy after surgery, improving treatment decision-making SAN FRANCISCO, Sept. 17, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that data featured in an oral presentation at the 56(th) Annual Meeting of the American Society for Radiation Oncology (ASTRO) demonstrates convincing evidence of the...

2014-09-15 23:07:35

Cianna Medical, Inc: Studies show benefit of targeted radiation for early-stage breast cancer Aliso Viejo, Calif. (PRWEB) September 15, 2014 Cianna Medical, Inc., a women’s health company, today announced five-year results for the first 200 hundred patients treated with the SAVI® breast brachytherapy applicator, including excellent local control, low rates of toxicities and excellent cosmetic results. An additional study of nearly 600 patients with over three years of follow-up...

2014-09-04 23:08:00

Long-term results show good local control, low toxicity with strut-based brachytherapy Aliso Viejo, CA (PRWEB) September 04, 2014 Cianna Medical, Inc., a women’s health company, today announced the release of long-term data supporting the efficacy and safety of breast brachytherapy with the SAVI® applicator. Researchers reported five-year results for the first 100 patients treated with strut-based brachytherapy, including favorably low rates of local recurrence and toxicities, as...

2014-09-04 08:31:36

ThermoDox® Combined with Mild Local Hyperthermia is Safe and Produces Compelling Objective Local Responses in RCW Breast Cancer Patients LAWRENCEVILLE, N.J., Sept. 4, 2014 /PRNewswire/ -- September 4, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that data from two Phase I studies on ThermoDox® in recurrent chest wall breast cancer were published in the International Journal of Hyperthermia. The article, titled "Two phase 1...

2014-08-04 13:00:53

Cancer Research UK Cancer Research UK scientists have found a new use for an old drug by showing that it shrinks a particular type of pancreatic cancer tumor and stops it spreading, according to research published in Gut. "It's a crucial step forward in developing new treatments for this devastating disease..." - Dr Jennifer Morton, study author The scientists, at the Cancer Research UK Beatson Institute and the University of Glasgow, treated mice with pancreatic cancers caused by...

2014-07-31 08:36:39

First MRI-Guided Radiation Therapy System to be installed on the U.S. Eastern Seaboard CLEVELAND, July 31, 2014 /PRNewswire/ -- The Sylvester Comprehensive Cancer Center at the University of Miami has become the fourth U.S. customer and the first hospital on the east coast to acquire an MRI-guided radiation therapy system from ViewRay(TM) Incorporated, a privately held medical device company. The MRIdian(TM) (me-rid-i-an) system is the first and only FDA cleared system of its kind...

2014-07-28 13:22:50

Cancer Research UK Cancer Research UK scientists at Barts Cancer Institute have found that targeting a molecule in blood vessels can make cancer therapy significantly more effective, according to research published in Nature today (Sunday). The team at Barts Cancer Institute, part of Queen Mary University of London, have found that a molecule, called focal adhesion kinase (FAK), signals the body to repair itself after chemotherapy or radiotherapy, which kill cancer cells by damaging...

2014-07-24 08:33:56

ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Refractory Patients LAWRENCEVILLE, N.J., July 24, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox® in Recurrent Chest Wall Breast Cancer (RCWBC). The trial is designed to enroll 20 patients at several U.S. clinical sites and is evaluating ThermoDox in combination with mild hyperthermia. Of the 13 patients...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.